Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

C-Section scar healing: which stitch method works best?

NCT ID NCT07611331

Knowledge-focused Sponsor: Hédi Chaker Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 384 women having their first C-section to compare two methods of closing the uterus: one layer of stitches vs. two layers. The goal was to see which method leads to better scar healing and fewer problems like pain or irregular bleeding. Researchers used ultrasound to measure scar thickness and defects at 6 weeks and 6 months after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
surgical procedure (single-layer or double-layer uterine closure)
What this could lead to
If one technique proves better, it could guide surgeons to use the method that reduces scar defects and related symptoms like pain or abnormal bleeding.
What could go wrong
This is a completed study, but results may not apply to all women or settings. The findings are based on ultrasound measurements, not long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

384 people

The number who actually took part.

Started

Jan 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women aged 18 years or older * Singleton pregnancy * Gestational age ≥ 37 weeks (term pregnancy) * Scheduled or emergency primary cesarean section (first cesarean delivery, no previous uterine scar) * Low transverse uterine incision (Pfannenstiel or Joel-Cohen approach) * Ability to provide written informed consent * Willingness to attend follow-up visits at 6 weeks and 6 months postoperatively * Patient affiliated to a social security system or equivalent healthcare coverage Exclusion Criteria: * Previous uterine surgery (prior cesarean section, myomectomy, uterine perforation, or any procedure leaving a uterine scar) * Multiple pregnancy (twins or higher-order multiples) * Preterm delivery (gestational age \< 37 weeks) * Classical (vertical) or inverted T uterine incision * Placenta previa or placenta accreta spectrum disorder * Active uterine infection or chorioamnionitis at time of surgery * Coagulation disorders or anticoagulant therapy * Immunosuppressive therapy or conditions affecting wound healing (systemic corticosteroids, immunosuppressants) * Severe maternal comorbidities (uncontrolled diabetes, connective tissue disorders, chronic renal failure) * Participation in another interventional clinical trial * Patient unable to attend scheduled follow-up visits * Patient unable to understand or sign informed consent * Fetal demise or major fetal malformation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Amenorrhea secondary are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Metrorrhagia Pelvic Pain secondary amenorrhea

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Amenorrhea secondary Cesarean scar defect (isthmococele) Metrorrhagia Pelvic pain Spotting

Contacts and locations

Locations

  • Hedi Chaker university hospital

    Sfax, Sfax Governorate, 3000, Tunisia

More trials for these conditions

Other studies related to the condition(s) this trial covers.